Utrecht, Netherlands

Merus B.v.


USPTO Granted Patents = 8



Trademarks = 2

Forward Citations = 298

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Ton Logtenberg (8 out of 59 patents)

silverMedal Linda Johanna Aleida Hendriks (3 out of 10 patents)

bronzeMedal Abraham Bout (3 out of 55 patents)

4.  Cornelis Adriaan De Kruif (3 out of 54 patents)

5.  Hendricus Renerus Jacobus Mattheus Hoogenboom (2 out of 28 patents)

6.  Patrick H C Van Berkel (2 out of 3 patents)

7.  Ronald Hendrik Peter Brus (2 out of 6 patents)

8.  Ronald Hendrik Brus (1 out of 3 patents)

9.  Patricius H C Van Berkel (1 out of 2 patents)

10.  Mark Throsby (50 patents)

11.  Rui Daniel Pinto (9 patents)

12.  Patricius Hendrikus Van Berkel (1 patent)

13.  Cecilia Anna Wilhelmina Geuijen (15 patents)

14.  Patrick Hendrikus Cornelis Van Berkel (1 patent)

15.  Hendricus Renerus Hoogenboom (0 patent)


8 patents:

Company Overview
Merus B.V. is a clinical-stage immuno-oncology company developing innovative full-length bispecific antibody therapeutics, referred to as Biclonics. Our lead product candidate, zenocutuzumab, is currently being evaluated in a Phase 1/2 clinical trial for various types of solid tumors. Merus' unique Biclonics platform allows for the precise targeting of multiple pathways to enhance tumor cell killing and potentially overcome treatment resistance.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#19 in Utrecht

#750 in Netherlands

Utrecht, NL
Utrecht, Netherlands
Forward Citations = 298

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Merus B.v.. Retrieved from https://idiyas.com/company/merus-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…